Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 86 Lung Neoplasms 32 Small Cell Lung Carcinoma 18 Melanoma 17 Mesothelioma 13 Neoplasms 11 Colorectal Neoplasms 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 7 Neoplasm Metastasis 7 Mesothelioma, Malignant 7 Carcinoma, Transitional Cell 7 Ovarian Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Liver Neoplasms 5 Endometrial Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Kidney Neoplasms 4 Brain Neoplasms 4 Carcinoma, Merkel Cell 3 Skin Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Lung Diseases 2 Head and Neck Neoplasms 2

Interventions

pembrolizumab 2 toripalimab 1 sintilimab 1 pemigatinib 1 osimertinib 1 durvalumab 1 Vinorelbine 1 Platinum Compounds 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × Ipilimumab × Thoracic × Clear all

NCT03351361 2023-03-01

eNERGY

Rennes University Hospital

Phase 3 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡